FENC
Fennec Pharmaceuticals Inc.
$6.49
+$0.17(+2.61%)
25
Overall
40
Value
10
Tech
--
Quality
Market Cap
$236.01M
Volume
125.73K
52W Range
$4.68 - $9.92
Target Price
$15.14
Order:
Income Statement
| Metric | Trend | Chart | 2022 Dec | 2023 Dec | 2024 Dec |
|---|---|---|---|---|---|
| REVENUE | |||||
| Total Revenue | $1.5M | $21.3M | -- | ||
| Total Revenue | $1.5M | $21.3M | -- | ||
| COST OF GOODS SOLD | |||||
| Cost of Revenue | $86.0K | $1.3M | -- | ||
| GROSS PROFIT | |||||
| Gross Profit | $1.4M | $20.0M | -- | ||
| OPERATING EXPENSES | |||||
| Operating Expenses | $24.2M | $33.1M | -- | ||
| Research & Development | $3.5M | $56.0K | -- | ||
| Research Expense | $3.5M | $56.0K | -- | ||
| Selling, General & Administrative | $20.5M | $32.7M | -- | ||
| Selling & Marketing Expenses | $2.8M | $12.1M | -- | ||
| General & Administrative Expenses | $17.7M | $20.6M | -- | ||
| Depreciation & Amortization | $149.0K | $287.0K | -- | ||
| Depreciation & Amortization | $149.0K | $287.0K | -- | ||
| Amortization | $149.0K | $287.0K | -- | ||
| OPERATING INCOME | |||||
| Operating income | $-22.7M | $-13.1M | -- | ||
| EBITDA | $-22.6M | $-12.4M | -- | ||
| NON-OPERATING ITEMS | |||||
| Interest Expense (Non-Operating) | $978.0K | $3.4M | -- | ||
| Intinc | $195.0K | $441.0K | -- | ||
| Net Non-Operating Interest Income/Expense | $-783.0K | $-3.0M | -- | ||
| Other Income/Expense | $184.0K | $39.0K | -- | ||
| PRE-TAX INCOME | |||||
| EBIT | $-22.7M | $-12.7M | -- | ||
| Pre-Tax Income | $-23.7M | $-16.1M | -- | ||
| NET INCOME | |||||
| Net Income | $-23.7M | $-16.1M | -- | ||
| Net Income (Continuing Operations) | $-23.7M | $-16.1M | -- | ||
| Net Income (Discontinued Operations) | $-23.7M | $-16.1M | -- | ||
| Net Income (Common Stockholders) | $-23.7M | $-16.1M | -- | ||
| Normalized Income | $-17.4M | $-11.8M | -- | ||
| TOTALS | |||||
| Total Expenses | $24.3M | -- | -- | ||
| SHARE & EPS DATA | |||||
| Average Shares Outstanding | $26.3M | $265.7M | -- | ||
| Average Shares Outstanding (Diluted) | $26.3M | $26.6M | -- | ||
| Shares Outstanding | $28.1M | $28.1M | $27.5M | ||
| Basic EPS | $-0.90 | $-0.06 | -- | ||
| Basic EPS (Continuing Operations) | $-0.90 | $-0.06 | -- | ||
| Diluted EPS | $-0.90 | $-0.60 | $-0.06 | ||
| Diluted EPS (Continuing Operations) | $-0.90 | $-0.60 | -- | ||
| OTHER METRICS | |||||
| Other Costof Revenue | $86.0K | $1.3M | -- | ||
| Other Gand A | $17.7M | $20.6M | -- | ||
Financial data is updated quarterly and may not reflect the most recent earnings.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | FENC | $6.49 | +2.6% | 125.73K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Fennec Pharmaceuticals Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW